Health ❯ Medicine ❯ Clinical Trials

Drug Development

Combination Therapy Phase 1 Trials Polilaminina Lepodisiran Therapeutic Targets CoronationBio Castration-Resistant Prostate Cancer DKK1 Blockade Polylaminin Targeted Therapy Novo Nordisk Eli Lilly Spinal Cord Injury Translational Medicine

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

The findings set up a phase 3 test before doctors can use the drug widely.

Stories older than 24h

Low-Dose THC Paired With Celecoxib Improves Cognition and Alzheimer’s Pathology in Mice

Study Finds TGF-β Builds Dual Immune Barrier in Metastatic Colorectal Cancer

Blocking DKK1 Reprograms Neutrophils and Revives Immunotherapy in Bone Metastases

Astrocyte-Derived Peptide Achieves Nausea-Free Weight Loss in Animal Models

Illusia Probe Maps Signaling That Drives Breast Cancer Cell Invasion